These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 24858366

  • 1. Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents.
    Wiley JL, Walentiny DM, Wright MJ, Beardsley PM, Burston JJ, Poklis JL, Lichtman AH, Vann RE.
    Eur J Pharmacol; 2014 Aug 15; 737():97-105. PubMed ID: 24858366
    [Abstract] [Full Text] [Related]

  • 2. Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice.
    Walentiny DM, Vann RE, Wiley JL.
    Neuropharmacology; 2015 Jun 15; 93():237-42. PubMed ID: 25698527
    [Abstract] [Full Text] [Related]

  • 3. Simultaneous inhibition of fatty acid amide hydrolase and monoacylglycerol lipase shares discriminative stimulus effects with Δ9-tetrahydrocannabinol in mice.
    Hruba L, Seillier A, Zaki A, Cravatt BF, Lichtman AH, Giuffrida A, McMahon LR.
    J Pharmacol Exp Ther; 2015 May 15; 353(2):261-8. PubMed ID: 25711338
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB1 receptor-mediated discriminative stimulus in mice.
    Owens RA, Mustafa MA, Ignatowska-Jankowska BM, Damaj MI, Beardsley PM, Wiley JL, Niphakis MJ, Cravatt BF, Lichtman AH.
    Neuropharmacology; 2017 Oct 15; 125():80-86. PubMed ID: 28673548
    [Abstract] [Full Text] [Related]

  • 5. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
    Guindon J, Lai Y, Takacs SM, Bradshaw HB, Hohmann AG.
    Pharmacol Res; 2013 Jan 15; 67(1):94-109. PubMed ID: 23127915
    [Abstract] [Full Text] [Related]

  • 6. The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport.
    Solinas M, Tanda G, Justinova Z, Wertheim CE, Yasar S, Piomelli D, Vadivel SK, Makriyannis A, Goldberg SR.
    J Pharmacol Exp Ther; 2007 Apr 15; 321(1):370-80. PubMed ID: 17210800
    [Abstract] [Full Text] [Related]

  • 7. The effects of fatty acid amide hydrolase and monoacylglycerol lipase inhibitor treatments on lipopolysaccharide-induced airway inflammation in mice.
    Abohalaka R, Bozkurt TE, Nemutlu E, Onder SC, Sahin-Erdemli I.
    Pulm Pharmacol Ther; 2020 Jun 15; 62():101920. PubMed ID: 32416152
    [Abstract] [Full Text] [Related]

  • 8. Dopaminergic augmentation of delta-9-tetrahydrocannabinol (THC) discrimination: possible involvement of D(2)-induced formation of anandamide.
    Solinas M, Tanda G, Wertheim CE, Goldberg SR.
    Psychopharmacology (Berl); 2010 Apr 15; 209(2):191-202. PubMed ID: 20179908
    [Abstract] [Full Text] [Related]

  • 9. Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo.
    Long JZ, Nomura DK, Vann RE, Walentiny DM, Booker L, Jin X, Burston JJ, Sim-Selley LJ, Lichtman AH, Wiley JL, Cravatt BF.
    Proc Natl Acad Sci U S A; 2009 Dec 01; 106(48):20270-5. PubMed ID: 19918051
    [Abstract] [Full Text] [Related]

  • 10. Δ9-tetrahydrocannabinol and endocannabinoid degradative enzyme inhibitors attenuate intracranial self-stimulation in mice.
    Wiebelhaus JM, Grim TW, Owens RA, Lazenka MF, Sim-Selley LJ, Abdullah RA, Niphakis MJ, Vann RE, Cravatt BF, Wiley JL, Negus SS, Lichtman AH.
    J Pharmacol Exp Ther; 2015 Feb 01; 352(2):195-207. PubMed ID: 25398241
    [Abstract] [Full Text] [Related]

  • 11. Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain.
    Kinsey SG, Long JZ, O'Neal ST, Abdullah RA, Poklis JL, Boger DL, Cravatt BF, Lichtman AH.
    J Pharmacol Exp Ther; 2009 Sep 01; 330(3):902-10. PubMed ID: 19502530
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay.
    Kinsey SG, O'Neal ST, Long JZ, Cravatt BF, Lichtman AH.
    Pharmacol Biochem Behav; 2011 Mar 01; 98(1):21-7. PubMed ID: 21145341
    [Abstract] [Full Text] [Related]

  • 13. Cannabinoid CB1 Discrimination: Effects of Endocannabinoids and Catabolic Enzyme Inhibitors.
    Leonard MZ, Alapafuja SO, Ji L, Shukla VG, Liu Y, Nikas SP, Makriyannis A, Bergman J, Kangas BD.
    J Pharmacol Exp Ther; 2017 Dec 01; 363(3):314-323. PubMed ID: 28947487
    [Abstract] [Full Text] [Related]

  • 14. Effects of fatty acid amide hydrolase (FAAH) inhibitors on working memory in rats.
    Panlilio LV, Thorndike EB, Nikas SP, Alapafuja SO, Bandiera T, Cravatt BF, Makriyannis A, Piomelli D, Goldberg SR, Justinova Z.
    Psychopharmacology (Berl); 2016 May 01; 233(10):1879-88. PubMed ID: 26558620
    [Abstract] [Full Text] [Related]

  • 15. The role of CB1 in intestinal permeability and inflammation.
    Karwad MA, Couch DG, Theophilidou E, Sarmad S, Barrett DA, Larvin M, Wright KL, Lund JN, O'Sullivan SE.
    FASEB J; 2017 Aug 01; 31(8):3267-3277. PubMed ID: 28404744
    [Abstract] [Full Text] [Related]

  • 16. Dual fatty acid amide hydrolase and monoacylglycerol lipase blockade produces THC-like Morris water maze deficits in mice.
    Wise LE, Long KA, Abdullah RA, Long JZ, Cravatt BF, Lichtman AH.
    ACS Chem Neurosci; 2012 May 16; 3(5):369-78. PubMed ID: 22860205
    [Abstract] [Full Text] [Related]

  • 17. Inhibitors of endocannabinoid-metabolizing enzymes reduce precipitated withdrawal responses in THC-dependent mice.
    Schlosburg JE, Carlson BL, Ramesh D, Abdullah RA, Long JZ, Cravatt BF, Lichtman AH.
    AAPS J; 2009 Jun 16; 11(2):342-52. PubMed ID: 19430909
    [Abstract] [Full Text] [Related]

  • 18. Peripheral antinociceptive effects of inhibitors of monoacylglycerol lipase in a rat model of inflammatory pain.
    Guindon J, Guijarro A, Piomelli D, Hohmann AG.
    Br J Pharmacol; 2011 Aug 16; 163(7):1464-78. PubMed ID: 21198549
    [Abstract] [Full Text] [Related]

  • 19. Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates.
    Justinova Z, Mangieri RA, Bortolato M, Chefer SI, Mukhin AG, Clapper JR, King AR, Redhi GH, Yasar S, Piomelli D, Goldberg SR.
    Biol Psychiatry; 2008 Dec 01; 64(11):930-7. PubMed ID: 18814866
    [Abstract] [Full Text] [Related]

  • 20. Discriminative Stimulus Properties of the Endocannabinoid Catabolic Enzyme Inhibitor SA-57 in Mice.
    Owens RA, Ignatowska-Jankowska B, Mustafa M, Beardsley PM, Wiley JL, Jali A, Selley DE, Niphakis MJ, Cravatt BF, Lichtman AH.
    J Pharmacol Exp Ther; 2016 Aug 01; 358(2):306-14. PubMed ID: 27307500
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.